Trial Profile
Multi-Center Study Comparing Efficacy and Tolerability of TRAVATAN BAK-free (0.004% Travoprost) in Patients Previously on Latanoprost Ophthalmic Solution 0.005% Monotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Oct 2017
Price :
$35
*
At a glance
- Drugs Travoprost (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Alcon
- 13 Apr 2015 New trial record